Baxion
Screening
Tags
Alerts
Theme
Xenetic Biosciences, Inc.
XBIO
·
NASDAQ
·
$3.07
Share Price as of 11/2
·
$6M
Market Cap as of 11/2
Categorized
Chronological
Ownership
Credit
Contracts
Plans
Incorporation
Transcripts
Tags
Financials
Filter
10-Q
Q2 ended 06/30/26
08/06/26
10-Q
Q1 ended 03/31/26
05/12/26
10-K/A
FY 2025
04/24/26
10-K
FY 2025
03/12/26
10-Q
Q3 ended 09/30/25
11/12/25
Disclosures
Filter
8-K
Current report
09/23/26
8-K
Current report
09/16/26
8-K
Current report
08/07/26
8-K
Results of Operations
05/13/26
8-K
Current report
04/24/26
Prospectuses and Registrations
Filter
424B5
Prospectus supplement
10/14/25
424B5
Prospectus supplement
10/10/25
S-3
Shelf registration
10/21/24
S-8
Registration of securities for employees
12/30/21
424B5
Prospectus supplement
11/19/21
Proxies
Filter
DEFA14A
Additional proxy materials
12/11/25
DEF 14A
Definitive proxy
10/31/25
DEFA14A
Additional proxy materials
10/31/25
DEF 14A
Definitive proxy
10/31/24
DEFA14A
Additional proxy materials
10/31/24
Ownership
Filter
SC 13G
Beneficial ownership
09/18/26
SC 13G
Beneficial ownership
05/29/26
SC 13G/A
Beneficial ownership (amended)
05/14/26
Form 4
Insider transaction
04/23/26
SC 13G
Beneficial ownership
02/12/26
Other
Filter
ARS
Annual report to shareholders
10/31/25
EFFECT
Request for effectiveness
11/01/24
ARS
Annual report to shareholders
10/31/24
CORRESP
Correspondence with the SEC
10/30/24
UPLOAD
Letter from the SEC
10/25/24
Latest Filings
Filter
8-K
Current report
09/23/26
8-K
Current report
09/16/26
8-K
Current report
08/07/26
10-Q
Q2 ended 06/30/26
08/06/26
8-K
Results of Operations
05/13/26
Ownership
Filter
SC 13G
Beneficial ownership
09/18/26
SC 13G
Beneficial ownership
05/29/26
SC 13G/A
Beneficial ownership (amended)
05/14/26
Form 4
Insider transaction
04/23/26
SC 13G
Beneficial ownership
02/12/26